(Q34660785)

3 August 2017

1 reference

title

Capecitabine: fulfilling the promise of oral chemotherapy (English)

1 reference

3 August 2017

1 reference

1 reference

Jimmy J Hwang

1

1 reference

3 August 2017

John L Marshall

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Expert Opinion on Pharmacotherapy

3 August 2017

published in

1 reference

3 August 2017

volume

3

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

733-743

1 reference

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Multicenter, Phase II study of capecitabine in taxane-pretreated metastatic breast carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Phase II study of oral capecitabine in patients with advanced or metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Capecitabine in the treatment of metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Dose-escalating study of capecitabine plus gemcitabine combination therapy in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

Body surface area as a determinant of pharmacokinetics and drug dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.6.733

21 January 2018

Identifiers

DOI

10.1517/14656566.3.6.733

1 reference

3 August 2017

1 reference